Jemincare
Clinical trials sponsored by Jemincare, explained in plain language.
-
New targeted pill takes on chemotherapy for KRAS-mutant lung cancer
Disease control Not yet recruitingThis study tests a new drug, JMKX001899, against standard chemotherapy (docetaxel) in people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12C. Participants must have already tried at least one prior treatment. The goal is to see if the …
Phase: PHASE3 • Sponsor: Jemincare • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New shot aims to stop stubborn hives when allergy pills fail
Symptom relief Not yet recruitingThis study tests an injection called JYB1904 for adults with chronic spontaneous urticaria (long-term hives) that still cause itching and welts despite taking antihistamines. About 180 participants will receive either the drug or a placebo to see if it reduces itch and hive activ…
Phase: PHASE3 • Sponsor: Jemincare • Aim: Symptom relief
Last updated May 26, 2026 07:43 UTC
-
New shot could quiet constant sniffles and sneezes
Symptom relief Not yet recruitingThis study tests an injection called JYB1904 for people with year-round allergic rhinitis (constant nasal allergies). About 135 adults will receive either the drug or a placebo alongside their usual allergy meds. The goal is to see if the injection reduces symptoms like runny nos…
Phase: PHASE2 • Sponsor: Jemincare • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC
-
New allergy shot for teens enters early testing
Symptom relief Not yet recruitingThis study tests a new injection called JYB1904 in 12 teenagers aged 12-17 with allergic diseases like food allergies, hay fever, asthma, or hives. The main goal is to check if the drug is safe and how the body processes it. This is an early-phase trial, so it focuses on safety a…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Symptom relief
Last updated May 20, 2026 11:58 UTC
-
New kidney disease drug candidate put through interaction tests in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests how a new drug called JMKX003142 interacts with other common medications in 112 healthy Chinese adults. Participants will take the study drug along with other drugs to see how the body processes them. The goal is to gather safety and interaction data,…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated May 26, 2026 07:48 UTC
-
Heart safety check for experimental kidney drug
Knowledge-focused Not yet recruitingThis early-stage study checks whether a single dose of JMKX003142, a drug being developed for polycystic kidney disease, changes the heart's electrical activity in 24 healthy Chinese adults. Participants will be randomly assigned to receive the drug or a placebo, and their heart …
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated May 26, 2026 07:47 UTC
-
Healthy men to swallow radioactive drug for science
Knowledge-focused Not yet recruitingThis early-stage study in 8 healthy Chinese men aims to understand how the experimental drug JMKX003142 is absorbed, broken down, and eliminated from the body. Participants will receive a radioactive form of the drug to track its path. This study does not offer any treatment bene…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated May 26, 2026 07:24 UTC
-
New drug interaction study launches for kidney disease treatment
Knowledge-focused Not yet recruitingThis study tests how a new drug called JMKX003142 interacts with two other medicines (amiodarone and febuxostat) in healthy Chinese adults. The goal is to understand how the body processes these drugs together, which will help guide future dosing for people with autosomal dominan…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC